首页> 外文期刊>Folia histochemica et cytobiologica >Immunohistochemical assay of p53, cyclin D1, c-erbB2, EGFr and Ki-67 proteins in HPV-positive and HPV-negative cervical cancers.
【24h】

Immunohistochemical assay of p53, cyclin D1, c-erbB2, EGFr and Ki-67 proteins in HPV-positive and HPV-negative cervical cancers.

机译:HPV阳性和HPV阴性宫颈癌中p53,细胞周期蛋白D1,c-erbB2,EGFr和Ki-67蛋白的免疫组织化学测定。

获取原文
获取原文并翻译 | 示例
           

摘要

The purpose of the present study was to analyse clinical correlation between HPV type 16 and 18 infection, expression of p53, cyclin D1, Ki-67, c-erbB2 and EGFr gene products in cervical cancer cells as well as their nuclear ploidy. The morphological parameters evaluated, such as differentiation of carcinomas, vascular invasion, ploidy and expression of oncogenic proteins, indicate the increased biological malignancy of HPV 16/18-positive carcinomas. The majority of them were poorly differentiated, revealed significantly higher frequence of vascular invasion (p<0.05), were more frequently aneuploid and showed overexpression of cyclin D1. The comparison of the data obtained with the mortality rate of the patients suggests that the overexpression of EGFr and moderate expression of Ki-67 seem to be unfavorable prognostic factors, regardless of the presence of HPV 16/18.
机译:本研究的目的是分析宫颈癌细胞中HPV 16型和18型感染,p53,cyclin D1,Ki-67,c-erbB2和EGFr基因产物的表达及其核倍性之间的临床相关性。评价的形态学参数,例如癌的分化,血管侵袭,倍性和致癌蛋白的表达,表明HPV 16/18阳性癌的生物恶性增加。它们中的大多数分化差,显示出显着更高的血管浸润频率(p <0.05),更频繁地为非整倍体并且显示出细胞周期蛋白D1的过表达。将获得的数据与患者的死亡率进行比较表明,无论是否存在HPV 16/18,EGFr的过表达和Ki-67的中等表达似乎都是不利的预后因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号